Introduction
Hypoglycaemia occurs in 30-50% of babies with Beckwith's syndrome, usually responds readily to treatment with corticosteroids and generally lasts less than 4 months (Beckwith, 1969) . Hypoglycaemia may occasionally be severe and prolonged when treatment becomes difficult. This includes frequent small feeds, glucagon, diazoxide, corticosteroids and epinephrine alone or in various combinations (Beckwith et al., 1964; Combs, Grunt and Brandt, 1966; Mariani et al., 1969; Schiff et al., 1973; Gotlin, 1973) and in one very severe case, partial pancreatectomy on the twenty-fourth day of life (Roe et al., 1973) .
The management of an infant, with Beckwith's syndrome, who had severe hypoglycaemia for 4 months, is now described.
Case report
After a pregnancy complicated by hydramnios and pre-eclamptic toxaemia, a boy was born by a normal delivery at 37 weeks' gestation, and weighed 3-2 kg (above the 90th centile).
Beckwith's syndrome was diagnosed after finding a very large tongue, linear indentations across the * Present address: Radcliffe Infirmary, Oxford. He remained asymptomatic until 10 weeks of age when he had a hypoglycaemic convulsion (dextrostix <25 mg/100 ml). He was treated with i.v. dextrose, diazoxide 50 mg, and later 75 mg, daily, and prednisone 5 mg increased to 10 mg daily. The blood glucose was frequently below 40 mg/100 ml during the next 3 weeks; the lowest level each day in relation to treatment is shown in Fig. 1 . Serum insulin levels remained elevated until he was 3-5 months of age (Table 2) . When 20 weeks old, he had two episodes of diarrhoea and vomiting for which it was thought that diazoxide might be partially responsible so it was discontinued. Serum insulin levels remained normal, and after a synacthen test had shown a satisfactory rise in plasma cortisol, prednisone was gradually withdrawn. Two weeks later blood glucose, serum insulin and cortisol levels were normal. Psychomotor development at 8 months was within the normal range.
Discussion
The severe prolonged hypoglycaemia in this case of Beckwith's syndrome may be fatal or cause mental retardation (Beckwith, 1969) , and illustrates some of the problems of management. The hypoglycaemia was due to excessive insulin secretion which has previously been demonstrated in only six cases (Beckwith et al., 1964; Cqmbs et al., 1966; Mariani et al., 1969; Schiff et al., 1973; Gotlin, 1973) . Treatment of these cases has been difficult and has consisted of intravenous and oral glucose, diazoxide, corticosteroids, glucagon, and epinephrine, alone, or in various combinations. However, side effects of these drugs may limit their usefulness. This case required 15 mg/kg diazoxide which is considerably more than the 10 mg/kg used by Schiff et al. (1973) , but similar to the dose used by Gotlin (1973) . Diazoxide was stopped in this patient when the serum insulin level was normal, as it was thought it might be contributing to his diarrhoea, but there was no evidence of bone marrow suppression as occurred in one of the cases reported by Combs et al. (1966) . Corticosteroids and glucagon were found by these authors to be effective in raising the blood sugar. However, in the case reported by Schiff et al. (1973) , glucagon caused an increase in insulin secretion and they concluded that it could exacerbate hypoglycaemia. It has to be given by i.m. injection, which limits its usefulness in prolonged cases. For the same reason, epinephine, as recommended by Schiff et al. (1973) is not practical for prolonged therapy. Intravenous and oral glucose, without hyperglycaemic drugs, are not sufficient to maintain the blood glucose as this case shows.
Although the diagnosis of Beckwith's syndrome was made a few minutes after birth, and hypoglycaemia anticipated and treated vigorously, the infant had two short periods of symptomatic hypoglycaemia. The first, at the age of 2 days was due to relying on oral and intravenous glucose alone to maintain the blood glucose level, and the second was at the age of 10 weeks. Treatment had been stopped gradually by the age of 1 month as the infant's blood glucose was satisfactory, but the insulin levels had not returned to normal.
In future cases, treatment should include diazoxide and corticosteroids as soon as the diagnosis of hypoglycaemia is made. These drugs should be withdrawn slowly when the blood glucose level is satisfactory and the serum insulin levels are normal. 
